Improving preregistration training.

Por Anderson, J., Harrigan, P.
Publicado em 1992

Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates

Por Harrigan, P. Richard, Larder, Brendan A.
Publicado em 2002

Kinetic studies of the acylation of pig muscle–d-glyceraldehyde 3-phosphate dehydrogenase by 1,3-diphosphoglycerate and of proton uptake and release in the overall enzyme mechanism...

Por Harrigan, P. J., Trentham, D. R.
Publicado em 1973

Reactions of d-glyceraldehyde 3-phosphate dehydrogenase with chromophoric thiol reagents

Por Harrigan, P. J., Trentham, D. R.
Publicado em 1971

Preregistration house officers in general practice. Training in general practice is also important for postregistration doctors.

Por Cunningham, B., Toms, B., Harrigan, P.
Publicado em 1995

Relative Replicative Fitness of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Isolates In Vitro

Por Harrigan, P. Richard, Bloor, Stuart, Larder, Brendan A.
Publicado em 1998

Communication in Medicine: A Core Curriculum

Por Cunningham, WF, Harrigan, P, Morgan, DC, Turner, JP
Publicado no J R Coll Physicians Lond (1997)

Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir

Por Côté, Hélène C. F., Brumme, Zabrina L., Harrigan, P. Richard
Publicado em 2001

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Por McGovern, Rachel A., Harrigan, P. Richard, Swenson, Luke C.
Publicado em 2010

Determination of transmembrane pH gradients and membrane potentials in liposomes.

Por Harrigan, P R, Hope, M J, Redelmeier, T E, Cullis, P R
Publicado em 1992

Four years' experience of a senior house officer rotation in general medicine including general practice.

Por Cunningham, W F, Harrigan, P, Morgan, D C, Turner, J P
Publicado em 1998

Uptake of basic amino acids and peptides into liposomes in response to transmembrane pH gradients.

Por Chakrabarti, A C, Clark-Lewis, I, Harrigan, P R, Cullis, P R
Publicado em 1992

Competitive Fitness Assays Indicate that the E138A Substitution in HIV-1 Reverse Transcriptase Decreases In Vitro Susceptibility to Emtricitabine

Por Sluis-Cremer, Nicolas, Huber, Kelly D., Brumme, Chanson J., Harrigan, P. Richard
Publicado em 2014

Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients

Por Ryscavage, Patrick, Kelly, Sean, Li, Jonathan Z., Harrigan, P. Richard, Taiwo, Babafemi
Publicado em 2014

The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus

Por Jones, Bradley R, Howe, Anita Y M, Harrigan, P Richard, Joy, Jeffrey B
Publicado no Virus Evol (2018)

Sources and Magnitude of Intralaboratory Variability in a Sequence-Based Genotypic Assay for Human Immunodeficiency Virus Type 1 Drug Resistance

Por Galli, R. A., Sattha, B., Wynhoven, B., O'Shaughnessy, M. V., Harrigan, P. R.
Publicado em 2003

“Test-and-Treat” Strategy for Control of HIV and AIDS Can Lead to a Decrease, Not an Increase, of Multidrug-Resistant Viruses

Por Gonzalez-Serna, A., Lima, V. D., Montaner, J. S., Harrigan, P. R., Brumme, C. J.
Publicado no Clin Infect Dis (2013)

Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance

Por Noguera-Julian, Marc, Edgil, Dianna, Harrigan, P Richard, Sandstrom, Paul, Godfrey, Catherine, Paredes, Roger
Publicado no J Infect Dis (2017)

Phenotypic Susceptibilities to Tenofovir in a Large Panel of Clinically Derived Human Immunodeficiency Virus Type 1 Isolates

Por Harrigan, P. R., Miller, M. D., McKenna, P., Brumme, Z. L., Larder, B. A.
Publicado em 2002

Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.

Por Harrigan, P R, Kinghorn, I, Bloor, S, Kemp, S D, Nájera, I, Kohli, A, Larder, B A
Publicado em 1996